AI Summary
CVS (CVS) is currently trading at $78.38, up 2.63% in the last 24 hours. The P/E ratio of 212.0 suggests the market has high growth expectations. We maintain a HOLD rating pending clearer directional signals.
Price
Volume
P/E Ratio
Insider
Price Chart
Price Data
Fundamentals
Technical Analysis Summary
27 indicators analyzed
Technical signals are mixed with 8 bullish and 8 bearish indicators. Wait for clearer direction before taking new positions.
Technical Indicators
Momentum & trend signals
π‘ Technical indicators are tools, not guarantees. Always combine with fundamental analysis.
MACD
(12, 26, 9)Bollinger Bands
Volatility & breakout detection
Stochastic Oscillator
Momentum indicator (14,3,3)
π Neutral: CVS stochastic is in the middle range (57.3). Wait for %K to enter overbought (80+) or oversold (20-) zones for clearer signals.
Average True Range (ATR)
π Normal volatility conditions - standard position sizing appropriate.
On-Balance Volume (OBV)
Volume-based momentum indicator
Price falling but volume accumulating - potential reversal signal
π Bullish divergence detected: OBV rising while price falls. This often signals accumulation before a price reversal. Smart money may be buying.
Pivot Points
Key Support & Resistance Levels
All Pivot Levels
Price is trading above the pivot point at $76.23, indicating bullish bias. Watch R1 ($77.44) as the next target.
Fibonacci Retracement
| Level | Price | Type | Distance |
|---|---|---|---|
| 0% | $85.15 | Resistance | -8.7% |
| 23.6% | $77.65 | Current | +0.8% |
| 38.2% | $73.01 | Support | +6.8% |
| 50%β¦ | $69.26 | Support | +11.6% |
| 61.8%β¦ | $65.50 | Support | +16.4% |
| 78.6% | $60.16 | Support | +23.2% |
| 100% | $53.36 | Support | +31.9% |
VWAP (Volume Weighted Avg Price)
Parabolic SAR
Stop and Reverse Indicator
π» Downtrend intact (8 days). SAR resistance at $82.24. Stay cautious.
Williams %R
βΈοΈ NEUTRAL: Williams %R at -42.8 - the stock is trading in the middle of its 14-day range. Momentum improving - watch for overbought zone above -20. Wait for extremes for clearer signals.
π CCI (Commodity Channel Index)
Momentum oscillator measuring price deviation
Strength: 50%
Previous CCI
-50.8
Typical Price
$77.82
SMA (20)
$78.30
Mean Deviation
$2.83
βΈοΈ NEUTRAL: CCI at -11.3 - price trading within normal range. Momentum improving - watch for +100 breakout for buy signal. Wait for CCI to break Β±100 levels for clearer trend signals.
20-Day CCI History
π―Aroon Indicator(25-period)
π DOWNTREND: Aroon Down (68) is above Aroon Up (64). Moderate bearish momentum. Watch for Aroon Down to rise above 70 for trend strengthening.
π Rate of Change (ROC)Sell
BearishUltimate Oscillator
Multi-timeframe momentum (7, 14, 28)
Keltner Channels
ATR-based volatility bands
βΈοΈ NEUTRAL: Price 78.31 is in the middle of the channel (EMA: 77.72). Channel width: 13.2%, ATR: 3.3% of price. No clear trend - wait for clearer signals.
TTM Squeeze
John Carter's Volatility Breakout
π NO SQUEEZE - BULLISH MOMENTUM: No squeeze currently (bands expanded). Momentum is positive and rising (3.96) - bullish continuation likely. Strong momentum - trend is healthy.
Elder Ray (Bull/Bear Power)
Dr. Alexander Elder's Power Index
π Classic Elder Buy Signal: Uptrend with Bear Power negative but rising - bulls pulling price up from oversold.
Force Index
Dr. Alexander Elder's Volume-Price Momentum
β οΈ Mixed signals. Short-term force positive (8.18M) but medium-term still negative (-16.84M). Potential early reversal - wait for 13-EMA confirmation.
Williams Alligator
Trend Direction & Strength
π Alligator is SATED - trend is losing momentum. Lines are converging. Previous neutral trend may be ending. Consider taking profits and wait for the next opportunity.
Donchian Channels
Richard Donchian's Breakout System (20-period)
Price at $78.31 is in the middle of the 20-day Donchian Channel (70.69 - 84.00). Channel is stable with 17.2% width. Current trend: Strong Downtrend.
Supertrend
ATR-Based Trend Following
π UPTREND active for 4 days. Price $78.31 is 3.6% above Supertrend $75.58. Moderate trend strength. The Supertrend line serves as trailing support - stay long with stops below Supertrend.
Choppiness Index
Trend vs Range Detection (14-period)
β³ TRANSITIONAL MARKET (CHOP: 41.7). The market is between trending and ranging. Choppiness is stable. Trading advice: WAIT for clearer signals or use smaller position sizes.
Valuation Metrics
Relative value indicators
π‘ PEG < 1 suggests undervalued relative to growth β’ EV/EBITDA accounts for debt
Historical Returns
Price performance across timeframes
π Insight: Compare returns across timeframes to identify trends and momentum shifts.
Seasonality Analysis
Market Comparison
Performance vs S&P 500
Dividend History
Past payments & growth
| Ex-Date | Amount |
|---|---|
| Jan 22, 2026Latest | $0.6650 |
| Oct 23, 2025 | $0.6650 |
| Jul 22, 2025 | $0.6650 |
| Apr 22, 2025 | $0.6650 |
| Jan 23, 2025 | $0.6650 |
| Oct 21, 2024 | $0.6650 |
| Jul 22, 2024 | $0.6650 |
| Apr 19, 2024 | $0.6650 |
Growth Metrics
Year-over-year performance
Growth rates calculated from trailing twelve months vs prior period
Analyst EPS Estimates
Consensus earnings projections
| Fiscal Year | Est. EPS | YoY Growth |
|---|---|---|
| FY26 | $7.12 | +1825.5% |
| FY27 | $8.11 | +13.9% |
| FY28 | $9.32 | +14.9% |
Based on analyst consensus estimates. Actual results may vary.
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
Recent News

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

FTC Settlement With Cigna's Pharmacy Benefit Manager Promises Cheaper Insulin, Boosts Dividend On Strong Quarterly Earnings

Is CVS Health Stock a Bad-News Buy?

'Big Short' Is Long On Molina Healthcare StockβWas He Big Wrong?

Humana Stock Down as Medicare Rate Proposal Hits Insurers

Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling

2 Dirt Cheap Stocks to Buy With $200 Right Now

FTC Delays Drug Middlemen Case While Talks Move Forward

UnitedHealth CEO Says Hospitals, Drug Prices Drive US Health Care Costs, Pledges ACA Rebates
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm
SEC Filings
πͺ Strengths
- βLimited positive signals in current data
π Opportunities
- βMarket conditions could present buying opportunities
β οΈ Weaknesses
- !Thin profit margins limit flexibility
π Threats
- βBroader market volatility remains a risk
β‘ Catalysts
- β Earnings releases and guidance updates
β οΈ Key Risks
- !Standard market and sector risks apply
Are you an AI agent?
Help improve this research! Submit corrections, updates, or suggestions via Moltbook.
AI Agent Feedback
Are you an AI agent? Help improve this analysis!